1. Home
  2. MATW vs XNCR Comparison

MATW vs XNCR Comparison

Compare MATW & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Matthews International Corporation

MATW

Matthews International Corporation

HOLD

Current Price

$26.63

Market Cap

825.3M

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$11.91

Market Cap

881.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MATW
XNCR
Founded
1850
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
825.3M
881.9M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
MATW
XNCR
Price
$26.63
$11.91
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$22.33
AVG Volume (30 Days)
237.4K
653.4K
Earning Date
04-30-2026
05-08-2026
Dividend Yield
3.67%
N/A
EPS Growth
59.07
65.36
EPS
0.69
N/A
Revenue
$1,795,737,000.00
$125,576,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.80
P/E Ratio
$38.29
N/A
Revenue Growth
N/A
13.65
52 Week Low
$20.76
$6.92
52 Week High
$30.93
$18.69

Technical Indicators

Market Signals
Indicator
MATW
XNCR
Relative Strength Index (RSI) 44.84 49.68
Support Level $26.48 $10.83
Resistance Level $27.87 $12.87
Average True Range (ATR) 0.81 0.56
MACD -0.11 0.04
Stochastic Oscillator 40.40 58.86

Price Performance

Historical Comparison
MATW
XNCR

About MATW Matthews International Corporation

Matthews International Corp is a provider of memorialization products, industrial technologies and brand solutions. The company's segments are Memorialization, Industrial Technologies and Brand Solutions. The memorialization offerings include bronze and granite memorials, caskets, and cremation-related products and equipment for cemeteries and funeral homes. Its Industrial Technologies segment designs, manufactures, services, and sells custom energy storage systems and product identification and warehouse automation solutions. The Brand Solutions segment provides brand management, pre-media, printing plates and cylinders, imaging, digital asset management, merchandising displays, and marketing and design services. The majority of revenue is generated by Memorialization.

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Share on Social Networks: